Pressure BioSciences Inc. PBIO Archives - Page 15 of 22

WednesdayMay 01, 2019 10:34 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces CEO Succession Plan

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences and other industries worldwide, today announced its CEO succession plan in light of its founder Richard T. Schumacher’s notification that he will step down as president and CEO effective September 9, 2019. Schumacher has been working with the company's directors on leadership succession planning for many months, including the selection of its SVP & Chief Commercial Officer Bradford A. Young, PhD, MBA in November 2018. To facilitate an orderly transition in leadership, the PBIO board…

WednesdayApr 24, 2019 11:16 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Host Teleconference to Discuss Q4 and FY2018 Financial Results and Provide Business Update

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences and other industries worldwide, today announced its plans to host a teleconference to discuss its Q4 and fiscal year 2018 financial results and to provide a business update. The teleconference, scheduled to be held on Thursday, April 25, 2019 at 4:30 PM ET, will include a company presentation followed by a question and answer period. Interested parties may listen to the teleconference live by dialing (844) 602-0380 (North America) or (862) 298-0970 (International), and stating the…

WednesdayMar 27, 2019 9:49 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Establishes Center of Excellence at Vogel Laboratory at NYU’s Center for Genomics and Systems Biology

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences and other industries worldwide, today announced the establishment of a Center of Excellence ("CoE") at Dr. Christine Vogel's laboratory at New York University's Center for Genomics and Systems Biology. As a CoE, the lab will have free use of PBIO's Barocycler 2320EXTREME (“2320EXT”) primary instrument system through the end of 2020. In addition, the collaboration will offer early access to new, modified, and/or improved versions of the 2320EXT instrument and its associated applications, as well as…

MondayMar 04, 2019 10:05 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Collaboration with The Steinbeis Centre

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments and platform technologies for the life sciences and other industries worldwide, today announced its entry into a collaboration with world-renowned German research organization The Steinbeis Centre for Biopolymer Analysis & Biomedical Mass Spectrometry. The collaboration seeks to combine unique capabilities of PBIO's patented pressure cycling technology ("PCT") for sample preparation, protein characterization and biotherapeutics quality control with the Steinbeis Centre's innovative PROTEX-MS instrument for elucidating structural details of antibody interactions to create a novel instrument system designed to accelerate the development of new protein therapeutics…

ThursdayFeb 21, 2019 11:49 am

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) CBD Oil Solutions Meet Nanoemulsion Specifications, Exhibit Minimal CBD Loss in Lab Testing

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences industry, today announced that analytical testing on hemp-derived CBD oil processed via its Ultra Shear Technology(TM) (“UST”) platform confirms its unique ability to achieve challenging criteria for creating highly-effective “nanoemulsions” of CBD oil in water. Per the update, testing results confirm these capabilities without CBD loss or modification throughout the entire UST process, providing greater than 99 percent recovery. “We asked an independent, university-affiliated laboratory to determine the size of oil droplets achieved in UST-processed CBD…

WednesdayFeb 13, 2019 10:29 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Video Demonstrating Capabilities of its Proprietary Ultra Shear Technology Platform

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences industry, today released a short video that demonstrates its proprietary Ultra Shear Technology (“UST”) platform and its ability to create nanoemulsions (extremely small, nanometer-scale oil droplets that effectively dissolve in water) to provide optimized bioavailability for absorption. “We have all observed how oil and water do not normally mix or dissolve in each other, and routinely separate after mixing,” Pressure BioSciences Chief Commercial Officer Dr. Bradford A. Young said in the news release. “Even with modern,…

MondayFeb 04, 2019 10:46 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Featured on Uptick Newswire

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and related services for the global life sciences industry, today announced that its president and CEO, Richard T. Schumacher, was featured on the Uptick Newswire Stock Day Podcast with Everett Jolly. During the interview, Schumacher discussed the company’s recently-announced collaboration with NutraFuels Inc., the commercial launch of its BioPharmaceuticals contract services business and the publication of over 20 scientific papers on PBIO’s unique pressure-based products throughout 2018. “We are a time-tested company with patents, products, a tremendous customer base, an expanding market, and increasing…

WednesdayJan 30, 2019 11:31 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Collaborate with NutraFuels, Inc. (NTFU) on New Generation of Health and Wellness Nutraceuticals

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences industry, this morning announced its collaboration with NutraFuels, Inc. (OTCQB: NTFU) to advance the development of a new generation of health and wellness nutraceutical products based on processing by PBIO’s proprietary Ultra Shear Technology (“UST”) platform. The companies intend development of a new generation of improved nutraceutical and other emulsion-based products, such as cosmetics, believing that nanoemulsions prepared by the UST Platform will have improved quality and effectiveness compared to current emulsions. “We are pleased to…

ThursdayJan 24, 2019 11:40 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Record Number of Scientific Papers Citing Benefits of its PCT Platform

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences industry, this morning announced worldwide publication by independent researchers of more than 20 scientific papers in 2018 citing advantages of the company's pressure cycling technology (“PCT”) platform. The publications, authored by scientists from industry, government and academia (a number of which are key opinion leaders in their field) provided a wide range of applications for PBIO's patented PCT Platform in cancer research, biomarker discovery, food safety, and proteomic and molecular biology studies. “We know that scientists…

MondayJan 07, 2019 10:39 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Eagerly-Anticipated Commercial Launch of Biopharmaceuticals Contract Services Business

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences industry, this morning announced the commercial launch of its Biopharmaceuticals Contract Services Business. The eagerly-anticipated launch follows PBIO’s December 2017 acquisition of the assets of BaroFold, Inc., including patents, equipment, and other intellectual property relating to its unique, high pressure-based protein disaggregation and refolding platform. PBIO expects the technology platform to offer substantial improvement in the quality and costs of manufacturing protein therapeutics. “We are excited to announce the launch of our Biopharmaceutical Contract Services Business…

Site Search

Company Search

Tag: Pressure BioSciences Inc. PBIO